Prevalence and Risk factors affecting center involved diabetic macular edema in patients with diabetic retinopathy Mahasarakham Hospital
Keywords:
diabetic retinopathy, center involved diabetic macular edema, risk factorsAbstract
Objective : This study aims to investigate the prevalence and risk factors for center involved diabetic macular edema in patients with diabetic retinopathy at Maha Sarakham Hospital.
Methods : This retrospective study was conducted by collecting data from the medical records of diabetic retinopathy (DR) patients receiving treatment at the chronic disease clinic of Maha Sarakham Hospital between January 1, 2020, and December 31, 2022. The sample size, containing 190 individuals, was determined using the formula for estimating the proportion of a single population. Data were analyzed using descriptive statistics and various inferential statistics, such as the chi-square test, T-test, simple logistic regression, and multiple logistic regression.
Results : From 190 patients with diabetic retinopathy, 64 had center involved diabetic macular edema due to diabetes, accounting for 33.68%. Factors influencing the occurrence of macular edema in diabetic retinopathy patients included body mass index (Adj.OR=1.12, 95%CI=1.03-1.22), systolic blood pressure (Adj.OR=1.05, 95%CI=1.03-1.09), LDL cholesterol levels (Adj.OR=1.01, 95%CI=1.00-1.01), HDL cholesterol levels (Adj.OR=0.95, 95%CI=0.91-0.99), triglyceride levels (Adj.OR=0.99, 95%CI=0.98-0.99), and glomerular filtration rate (Adj.OR=0.98, 95%CI=0.97-0.99).
Conclusion : The prevalence of center involved diabetic macular edema caused by diabetes among patients with diabetic retinopathy was 33.68%. Factors such as body mass index, systolic blood pressure, LDL cholesterol, HDL cholesterol, triglyceride levels, and glomerular filtration rate were found to significantly affect the development of macular edema in diabetic retinopathy patients. This result shows the urgency to implement cost-effective screening strategies to expand the scope of eye examinations for individuals with type 2 diabetes and provide treatment.
References
Ku WN, Tien PT, Lin CJ, Chiang CC, Hsia NY, Lai CT, et al. Changes of Estimated Glomerular Filtration Rate and Glycated Hemoglobin A1c in Diabetic Macular Edema Patients Treated by Ranibizumab and Aflibercept in the Tertiary Referral Hospital. Medicina (Kaunas). 2022 Aug 11;58(8):1081.
Mechanisms of Diabetic Complications | Physiological Reviews [Internet]. [cited 2023 Sep 11]. Available from: https://journals.physiology.org/doi/full/10.1152/physrev.00045.2011
นิภา วัธนเวคิน. การจัดการดูแลตนเองของผู้ป่วยจอประสาทตาเสื่อมจากเบาหวาน. รามาธิบดีพยาบาลสาร. 2550; 13(2): 97-105.
Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556-64.
ชายหาญ รุ่งศิริแสงรัตน์. ความชุกและปัจจัยเสี่ยงของการเกิดเบาหวานขึ้นจอประสาทตาในผู้ป่วยเบาหวานชนิดที่ 2 ในโรงพยาบาลพระสมุทรเจดีย์ สวาทยานนท์. วารสารสมาคมเวชศาสตร์ป้องกัน แห่งประเทศไทย. 2018;7(2):179-88.
นิภาพร พวงมี, กรรณิการ์ คำเตียม, สุภเลิศ ประคุณหังสิต. ความชุกและปัจจัยเสี่ยงของภาวะเบาหวานขึ้นจอตาในผู้ป่วยโรคเบาหวานชนิดที่ ๒ หน่วยตรวจโรคจักษุ โรงพยาบาลศิริราช. ธรรมศาสตร์เวชสาร. 2560;17(3):336-45.
Diep TM, Tsui I. Risk factors associated with diabetic macular edema. Diabetes Res Clin Pract. 2013;100(3):298-305.
Im JHB, Jin Y-P, Chow R, Yan P. Prevalence of diabetic macular edema based on optical coherence tomography in people with diabetes: A systematic review and meta-analysis. Survey of Ophthalmology. 2022;67(4):1244-51.
อาทิตย์ วีระเบญจพล. เบาหวานขึ้นตา หากไม่รีบรักษาอาจตาบอดได้. [อินเทอร์เน็ต]. 2565 [สืบค้น เมื่อ 12 มกราคม 2566]. เข้าถึงได้จาก: https://www.samitivejhospitals.com/th/article/
detail/diabetic-retinopathy.
Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844-51.
Acan D, Calan M, Er D, Arkan T, Kocak N, Bayraktar F, et al. The prevalence and systemic risk factors of diabetic macular edema: a cross-sectional study from Turkey. BMC Ophthalmology. 2018;18(1):91.
Jew OM, Peyman M, Chen TC, Visvaraja S. Risk factors for clinically significant macular edema in a multi-ethnics population with type 2 diabetes. Int J Ophthalmol. 2012;5(4):499-504
Lin Z, Wang FH, Wen L, Wang Y, Li D, Ding XX, et al. Prevalence of and risk factors for diabetic macular edema in a northeastern Chinese population. Int J Ophthalmol. 2022;15(2):320-6.
Graue-Hernandez EO, Rivera-De-La-Parra D, Hernandez-Jimenez S, Aguilar-Salinas CA, Kershenobich-Stalnikowitz D, Jimenez-Corona A. Prevalence and associated risk factors of diabetic retinopathy and macular oedema in patients recently diagnosed with type 2 diabetes. BMJ Open Ophthalmol. 2020;5(1):e000304.
Zhuang X, Cao D, Yang D, Zeng Y, Yu H, Wang J, et al. Association of diabetic retinopathy and diabetic macular oedema with renal function in southern Chinese patients with type 2 diabetes mellitus: a single-centre observational study. BMJ Open. 2019;9(9):e031194.
Benarous R, Sasongko MB, Qureshi S, Fenwick E, Dirani M, Wong TY, et al. Differential Association of Serum Lipids with Diabetic Retinopathy and Diabetic Macular Edema. Investigative Ophthalmology & Visual Science. 2011 Sep 27;52(10):7464–9.
Wang Y, Lin Z, Zhai G, Ding XX, Wen L, Li D, et al. Prevalence of and Risk Factors for Diabetic Retinopathy and Diabetic Macular Edema in Patients with Early- and Late-Onset Diabetes Mellitus. Ophthalmic Research. 2020 Apr 30;65(3):293–9.
Graue-Hernandez EO, Rivera-De-La-Parra D, Hernandez-Jimenez S, Aguilar-Salinas CA, Kershenobich-Stalnikowitz D, Jimenez-Corona A. Prevalence and associated risk factors of diabetic retinopathy and macular oedema in patients recently diagnosed with type 2 diabetes. BMJ Open Ophthalmology. 2020 Mar 1;5(1):e000304.
Acan D, Calan M, Er D, Arkan T, Kocak N, Bayraktar F, et al. The prevalence and systemic risk factors of diabetic macular edema: a cross-sectional study from Turkey. BMC Ophthalmology. 2018 Apr 12;18(1):91.
Panozzo G, Staurenghi G, Dalla Mura G, Giannarelli D, Alessio G, Alongi S, et al. Prevalence of diabetes and diabetic macular edema in patients undergoing senile cataract surgery in Italy: The DIabetes and CATaract study. European Journal of Ophthalmology. 2020 Mar 1;30(2):315–20.
Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye. 2004 Oct;18(10):963–83.
Hammes HP, Welp R, Kempe HP, Wagner C, Siegel E, Holl RW, et al. Risk Factors for Retinopathy and DME in Type 2 Diabetes-Results from the German/Austrian DPV Database. PLoS One. 2015;10(7):e0132492.
van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, et al. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol. 2003 Feb;121(2):245–51.
Retinal Hemodynamics in Early Diabetic Macular Edema | Diabetes | American Diabetes Association [Internet]. [cited 2023 Sep 11]. Available from: https://diabetesjournals.org/diabetes/article/55/3/813/12637/Retinal-Hemodynamics- in-Early-Diabetic-Macular
Zhuang X, Cao D, Yang D, Zeng Y, Yu H, Wang J, et al. Association of diabetic retinopathy and diabetic macular oedema with renal function in southern Chinese patients with type 2 diabetes mellitus: a single-centre observational study. BMJ Open. 2019 Sep 6;9(9):e031194.
Kang EYC, Chen TH, Garg SJ, Sun CC, Kang JH, Wu WC, et al. Association of Statin Therapy With Prevention of Vision-Threatening Diabetic Retinopathy. JAMA Ophthalmology. 2019 Apr 1;137(4):363–71.
Du M, Wu M, Fu D, Yang S, Chen J, Wilson K, et al. Effects of modified LDL and HDL on retinal pigment epithelial cells: a role in diabetic retinopathy? Diabetologia. 2013 Oct;56(10):2318–28.
Tomić M, Vrabec R, Bulum T, Ljubić S. HDL cholesterol is a protective predictor in the development and progression of retinopathy in type 1 diabetes: A 15-year follow-up study. Diabetes Research and Clinical Practice. 2022 Apr 1;186:109814.
Suzuki Y, Kiyosawa M. Relationship between Diabetic Nephropathy and Development of Diabetic Macular Edema in Addition to Diabetic Retinopathy. Biomedicines. 2023 May;11(5):1502.
Torres-Arellano JM, Tornero-Jimenez A, Sánchez-Ríos A, Olvera-Montaño O, Muñoz-Villegas P. Evaluation of the Relationship Between Diabetic Macular Edema and Renal Function in a Latino Population. Ophthalmol Ther. 2023 Oct;12(5):2745–55.
Temkar S, Karuppaiah N, Takkar B, Bhowmik D, Tripathi M, Ramakrishnan S, et al. Impact of estimated glomerular filtration rate on diabetic macular edema. Int Ophthalmol. 2018 Jun;38(3):1043–50.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Mahasarakham Hospital Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
วารสารนี้เป็นลิขสิทธิ์ของโรงพยาบาลมหาสารคาม
